1. Healthcare

Curriculum Vitae
PERSONAL INFORMATION
Paul Heath
WORK EXPERIENCE
2000–Present
Professor / Honorary Consultant
St. Georges, University of London, (United Kingdom)
Professor / Honorary Consultant
Paediatric Infectious Diseases
Institute for Infection and Immunity
Director, St Georges Vaccine Institute
January 1994–January 1999
Research Fellow / Honorary Consultant
Oxford Vaccine Group, Department of Paediatrics, John Radcliffe Hospital Oxford, (United Kingdom)
January 1998–June 1998
Locum Consultant Paediatrician (Paediatric Infectious Diseases Unit)
St Georges Hospital, London, (United Kingdom)
January 1987–December 1993
Paediatric Trainee
Royal Children's Hospital, Melbourne, (Australia)
EDUCATION AND TRAINING
–1985
M.B.B.S. (Honours).
Monash University, Melbourne, , (Australia)
–1993
Fellowship
Royal Australasian College of Physicians , (Australia)
–1997
Certificate of Completion of Specialist Training in Paediatrics
(United Kingdom)
–1999
Fellowship of the Royal College of Paediatrics and Child Health
(United Kingdom)
ADDITIONAL INFORMATION
Expertise
Publications
The epidemiology of vaccine preventable diseases; clinical vaccine trials, particularly in at-risk groups;
and perinatal infections.
PUBLICATIONS.
Original articles.
1. Booy R, Heath PT, Slack MPE, Begg N, Moxon ER. Surveillance of vaccine failures following
primary immunisation of infants with Hib conjugate vaccine: Evidence for protection without boosting.
Lancet 1997;349:1197-202.
2. Heath PT, Bowen Morris J, Griffiths D, Griffiths H, Crook D, Moxon ER. Antibody persistence and
Hib carriage following infant immunisation with PRP-T. Arch Dis Child 1997;77:488-492.
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 1 / 14
Curriculum Vitae
Paul Heath
3. Bell F, Heath P, Shackley F, et al. Effect of combination with an acellular pertussis, diphtheria,
tetanus vaccine on antibody response to Hib vaccine (PRP-T). Vaccine 1998;16(6):637-642.
4. Coen PG, Heath PT, Barbour ML, Garnett GP. Mathematical Models Of Haemophilus influenzae
Type b. Epidemiology and Infection. 1998;120:281-295 .
5. Moses Lahra M, Heath PT, Wilkinson AR, Jeffery HE, Isaacs D. Early-onset group B streptococcal
neonatal infection in Oxford. Archives of Disease in Childhood (Fetal and Neonatal), 1998;79:F148-9.
6. Shackley F, Roberts P, Heath P, Bowler I, Saunders N. Trough only monitoring of vancomycin in
neonates. Journal of Antimicrobial Chemotherapy 1998;41:141-2.
7. Coen PG, Heath PT, Garnett GP. The Hib immunization programme in the Oxford region: an
analysis of the impact of vaccine administration on the incidence of disease. Epidemiology and
Infection. 1999;123:389-402.
8. Bell F, Heath P, Shackley F, Maclennan J, Herbert M, Shearstone N, Diggle L, Moxon ER, Finn A.
Poor response to Hib (PRP-T) vaccine when combined with an acellular pertussis/diphtheria/tetanus
vaccine for primary immunization of infants. Biologicals 1999 Jun;27(2):113.
9. Bell F, Heath P, MacLennan J, Shackley F, Shearstone N, Diggle L, Thornton C, Griffiths H, Moxon
ER, Finn A. Adverse effects and sero-responses to an acellular pertussis/diphtheria/ tetanus vaccine
when combined with Hib vaccine in an accelerated schedule. European Journal of Pediatrics
1999;158:329-336
10. Moxon ER, Heath PT, Booy R, Azzopardi HJ, Slack MPE, Ramsay ME. The impact of Hib
conjugate vaccines in preventing invasive H. influenzae diseases in the UK. Vaccine 1999:17 S11S13.
11. Maclennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, Griffiths H, Hatzmann E,
Goilav C, Moxon ER. Safety, Immunogenicity and Induction of Immunological Memory by a
Serogroup C Meningococcal Conjugate Vaccine in Infants: A Randomised Controlled Trial. JAMA
2000;283:2795-2801.
12. Heath PT, Booy R, Azzopardi HJ, Slack MPE, Bowen-Morris J, Griffiths H, Ramsay ME, Deeks JJ,
Moxon ER. Antibody Concentration and Clinical Protection After Hib Conjugate Vaccination in the
United Kingdom. JAMA 2000; 284:2334-2340.
13. Heath PT, Booy R, Griffiths H, Clutterbuck E, Azzopardi HJ, Slack MPE, Fogarty J, Moloney AC,
Moxon ER. Clinical and Immunological Risk Factors Associated with Hib Conjugate Vaccine Failure in
Childhood.
Clinical Infectious Diseases 2000; 31:973-80.
14. Heath PT, Booy R, Azzopardi HJ, Slack MPE, Fogarty J, Moloney AC, Ramsay ME, Moxon ER.
Non Type b Haemophilus influenzae Disease: Clinical and Epidemiological Characteristics in the Hib
Vaccine Era. Pediatr Infect Dis J 2001:20:300-5
15. Heath PT, Booy R, McVernon J, Griffiths H, Bowen-Morris J, Slack MPE, Moloney AC, Ramsay
ME, Moxon ER. Hib Vaccination in Infants Born Prematurely. Archives of Disease in Childhood
2003;88:206-10.
16. N S Crowcroft, Robert Booy, Tim Harrison, Lin Spicer, Joseph Britto, Quen Mok, Paul Heath, Ian A
Murdoch, Maria Zambon, Rob George, and Elizabeth Miller. Severe and unrecognised Pertussis in
UK infants. Archives of Disease in Childhood 2003;88:802-6.
17. Luck S, Torry M, d'Agapeyeff K, Pitt A, Heath PT, Breathnach A, Bedford Russell A. Estimated
early-onset group B streptococcal neonatal disease. Lancet 2003; 361:1953-4.
18. Ramsay ME, McVernon J, Andrews NJ, Heath PT, Slack MP. Estimating Hib vaccine effectiveness
in England and Wales using the screening method. J Infect Dis 2003;188:481-5.
19. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O'Connell LAF, Cafferkey
M, Verlander NQ, Nicoll A, AC McCartney. Group B streptococcal disease in UK and Irish infants < 90
days of age. Lancet 2004;363:292-4.
20. Rothstein, E.; Kohl, K. S.; Ball, L.; Halperin, S. A.; Halsey, N.; Hammer, S. J.; Heath, P. T.; Hennig,
R.;
Kleppinger, C.; Labadie, J.Nodule at injection site as an adverse event following immunization: case
definition and guidelines for data collection, analysis, and presentation. Vaccine 2004;22: 575-585.
21. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, Efstratiou A.
Characterisation of
Group B Streptococci from Infants with Invasive Disease in England and Wales.
Clinical Infectious Disease 2004;38:1203-8.
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 2 / 14
Curriculum Vitae
Paul Heath
22. Collins C L, Ruggeberg JU, Balfour G, Tighe H, Archer M, Bowen-Morris J, Diggle L, Borrow R,
Balmer P, Buttery J P, Moxon E R, Pollard AJ, Heath P T. Immunogenicity and Immunological Memory
of Meningococcal C Conjugate Vaccine in Premature infants. Pediatric Infectious Diseases Journal
2005;24(11):966-8.
23. Huo Z. Sinha R. McNeela EA. Borrow R. Giemza R. Cosgrove C. Heath PT. Mills KH. Rappuoli R.
Griffin GE. Lewis DJ. Induction of protective serum meningococcal bactericidal and diphtherianeutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the
Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan.
Infection & Immunity 2005; 73(12):8256-65.
24. Haitham El Bashir, Paul T. Heath, Thomas Papa, Jens U Ruggeberg, Nik Johnson, Ruchi Sinha,
Gail Balfour and Robert Booy. Antibody responses to meningococcal (groups A, C, Y and W135)
polysaccharide diphtheria toxoid conjugate vaccine in children who previously received
meningococcal C conjugate vaccine. Vaccine. 2006; 24:2544-9.
25. David M. Vu, Paul T. Heath, Noel D. McCarthy, Andrew J.Pollard and Dan M. Granoff.
Effectiveness Analyses May Underestimate Protection of Infants after Group C Meningococcal
Immunization. The Journal of Infectious Diseases 2006;194(2):231-7.
26. Paul Clarke, Michael J Robinson, Ijaz Ahmad, Alison R Bedford-Russell, Jane E Connell, Peter J
Powell, Paul T Heath. Response of steroid-treated former preterm infants to a single dose of
meningococcal C conjugate vaccine. Vaccine. 2006;24(16):3273-8.
27. Nik G Johnson, Jens U Ruggeberg, Gail F Balfour, Y Chen Lee, Helen Liddy, Diane Irving, Joanna
Sheldon, Mary PE Slack, Andrew J Pollard, Paul T Heath. Reemergence of Haemophilus influenzae
type b associated with reduced antibody and avidity responses after primary immunization with
acellular pertussis-containing combination vaccines. Emerging Infectious Diseases 2006
Jun;12(6):937-41.
28. Conterno LO, Silva Filho CR, Rüggeberg JU, Heath PT. Conjugate vaccines for preventing
meningococcal C meningitis and septicaemia. Cochrane Database Syst Rev. 2006 Jul
19;3:CD001834
29. Kohl KS, Ball L, Gidudu J, Hammer SJ, Halperin S, Heath P, Hennig R, Labadie J, Rothstein E,
Schuind A, Varricchio F, Walop W; The Brighton Collaboration Local Reactions Working Group for
Abscess at Injection Site. Abscess at injection site: Case definition and guidelines for collection,
analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5821-38.
30. Jens U. Ruggeberg, Clare Collins, Paul Clarke, Nik Johnson, Ruchi Sinha, Neil Everest, John
Chang, Elaine Stanford, Paul Balmer, Ray Borrow, Sarah Martin, Michael J. Robinson, E Richard
Moxon, Andrew J. Pollard, Paul T. Heath. Immunogenicity and induction of immunological memory of
the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine. 2007 Jan
4;25(2):264-71.
31. Ladhani S, Slack PP, Heath PT, Ramsay ME. Changes in ascertainment of Hib and its influence
on the estimation of disease incidence in the United Kingdom. Epidemiol Infect. 2007 Jul;135(5):8617.
32. Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT.
Re-immunization with measles, tetanus, poliovirus, Haemophilus influenzae type b, meningococcal C
and
pneumococcal vaccines in children following hematopoietic stem cell transplantation.
Clin Infect Dis. 2007 Mar 1;44(5):625-34.
32. Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT.
Reimmunization of children after completion of standard chemotherapy for acute leukemia.
Clin Infect Dis. 2007 Mar 1;44(5):635-42.
33. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza
pandemic.
Paediatric Subgroup. Thomson A, Ajayi-Obe E, Coote N, Harnden A, Heath P, Mckenzie S.
Thorax 2007;62(Suppl I):i1–i13 and Journal of Infection 2006;53(Suppl 1):S1–S58.
34. Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Hennig R, Rothstein E,
Schuind A, Varricchio F; The Brighton Collaboration Local Reactions Working Group for Induration at
or near Injection Site. Induration at or near injection site: Case definition and guidelines for collection,
analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5839-57.
35. Halperin S, Kohl KS, Gidudu J, Ball L, Hammer SJ, Heath P, Hennig R, Labadie J, Rothstein E,
Schuind A, Varricchio F, Walop W; The Brighton Collaboration Local Reaction Working Group for
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 3 / 14
Curriculum Vitae
Paul Heath
Cellulitis at Injection Site. Cellulitis at injection site: Case definition and guidelines for collection,
analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5803-20
36. Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Varricchio F, Rothstein E,
Schuind A, Hennig R; The Brighton Collaboration Local Reaction Working Group for Swelling at or
near Injection Site. Swelling at or near injection site: Case definition and guidelines for collection,
analysis and presentation of immunization safety data. Vaccine. 2007 Aug 1;25(31):5858-74.
37. Crowcroft NS, Zambon M, Harrison TG, Mok Q, Heath P, Miller E. Respiratory syncytial virus
infection in infants admitted to paediatric intensive care units in London, and in their families. Eur J
Pediatr. 2007 May 31; [Epub ahead of print]
38. Roche A, Heath PT, Sharland M, Strachan D, Breathnach A, Haigh J, Young Y. Prevalence of
nasopharyngeal carriage of pneumococcus in preschool children attending day care in London.
Archives of Disease in Childhood 2007 Dec;92(12):1073-6.
39. S J C Cameron, G Allan, F Johnston, A Finn, PT Heath, R Booy. Severe complications of
chickenpox in hospitalised children in the UK and Republic of Ireland. Archives of Disease in
Childhood, 2007 Dec;92(12):1062-6.
40. Spyridis N, Chakraborty R, Sharland M, Heath PT. Early diagnosis of tuberculosis using an INFγ
assay in a child with HIV-1 infection and a very low CD-4 count. Scandinavian Journal of Infectious
Diseases 2007;39(10):919-21.
41. Lee YC, Kelly D, Yu L, Slack M, Booy R, Heath PT, Siegrist C, Moxon ER, Pollard AJ.
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of
high quality antibody. Clin Infect Dis. 2008 Jan 15;46(2):186-92.
42. Sarah Y Oh; David Griffiths; Tessa John; Yeh C Lee; Lymee M Yu; Noel McCarthy; Paul T Heath;
Derrick Crook; Mary Ramsay; E. Richard Moxon; Andrew J. Pollard. School-age children: a reservoir
for continued circulation of Haemophilus influenzae type b in the UK. Journal of Infectious Diseases
2008 May 1;197(9):1275-81.
43. Fernando A, Heath PT, Menson E. Antimicrobial policies in British and Irish neonatal units. Journal
of J Antimicrob Chemother. 2008 Mar;61(3):743-5.
44. Ladhani S, Heath PT, Ramsay ME, Slack MP. Changes in antibiotic resistance rates of invasive
Haemophilus influenzae isolates in England and Wales over the last 20 years. J Antimicrob
Chemother. 2008 Oct;62(4):776-9.
45. Liz Schroeder, Stavros Petrou, Gail Balfour, Oya Edamma, Paul T. Heath. The economic costs of
Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in
England. The European Journal of Health Economics 2009 Jul;10(3):275-85.
46. A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and
presentation of immunization safety data. Jane Gidudu, Katrin S. Kohl , Scott Halperin , Sandra Jo
Hammer, Paul T. Heath , Renald Hennig, Bernard Hoet , Edward Rothstein , Anne Schuind, Frederick
Varricchio , Wikke Walop, The Brighton Collaboration Local Reactions Working Group for A Local
Reaction at or near Injection Site. Vaccine. 2008 9;26(52):6800-13.
47. Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A; HPA GBS Working
Group. Group B streptococcal disease in infants: a case control study. Arch Dis Child. 2009
Sep;94(9):674-80.
48. Ladhani S, Paul T Heath, Mary E Ramsay, Mary PE Slack, Elizabeth Kibwana, Andrew J Pollard,
Robert Booy. Long-term immunological follow-up of children with Hib vaccine failure. Clin Infect Dis.
2009 Aug 1;49(3):372-80.
49. Ladhani, Shamez; Heath, Paul; Slack, Mary; McIntyre, Peter; Diez-Domingo, Javier; Campos
Marqués, José; Dagan, Ron; Ramsay, Mary. Haemophilus influenzae serotype b conjugate vaccine
failure in twelve countries with established national childhood immunisation programmes. Clin
Microbiol Infect. 2010 Jul;16(7):948-54. Epub 2009 Nov 4.
50. Vergnano S, Embleton ND, Collinson A, Menson E, Bedford Russell AR, Heath PT. Missed
opportunities for preventing GBS infections. Arch Dis Child Fetal Neonatal Ed. 2010;95(1):F72-3.
51. Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always
necessary? Harris RL, Modayil P, Adam J, Sharland M, Heath P, Planche T, Daya H. Int J Pediatr
Otorhinolaryngol. 2009 Sep;73(9):1297-301
52. Jessica M. Bate, Soonie R. Patel, Julia Chisholm, Paul T. Heath. Immunisation practices of
paediatric oncology and shared care oncology consultants: a United Kingdom survey. Pediatric blood
& cancer 2010;54(7):941-6
53. Shamez Ladhani, Mary P.E. Slack, Paul T. Heath, Anne von Gottberg, Manosree Chandra, Mary
E. Ramsay and EU-IBIS participants. Invasive Haemophilus influenzae disease in the post-vaccine
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 4 / 14
Curriculum Vitae
Paul Heath
era: data from European surveillance 1996-2006. Emerg Infect Dis. 2010 Mar;16(3):455-63.
54. Adebowale V, Baxter C, Elliman D, Green A, Guppy MJ, Hall A, Heath P, Heagerty T, Lindley K,
Miller E, Baxter DN. Updates from the 19(th) national immunisation conference for health care
workers: Manchester conference centre, December 2008. Hum Vaccin. 2010 Feb 19;6(2)
55. Ladhani S, Heath PT, Aibara RJ, Ramsay ME, Slack MP, Hibberd ML,Pollard AJ,Moxon ER,Booy
R. Long-term complications and risk of other serious infections following invasive Haemophilus
influenzae serotype b disease in vaccinated children. Vaccine. 2010 Mar 2;28(10):2195-200. Epub
2010 Jan 5.
56. Baba Inusa, Nimze Gadong, Michele Afif, Sarah Arnott, Paul Heath, Grant Marais, Helen Payne,
Paula Robertson, Olu Wilky, Mark Zuckerman, David C Rees. Pandemic influenza A (H1N1) virus
infections in children with sickle cell disease. Blood. 2010 Mar 18;115(11):2329-30.
57. Shamez Ladhani, Ray Borrow, Paul T Heath, Mary E Ramsay, Robert Booy. Low serum serotypespecific pneumococcal antibody concentrations in young children with Haemophilus influenzae
serotype b (Hib) vaccine failure. Vaccine. 2010 Jun 17;28(28):4440-4.
58. Soonie R.Patel, Jessica Bate, Ray Borrow, Paul T.Heath. Serotype-specific Pneumococcal
Antibody Concentrations In Children Treated For Acute Leukaemia. Arch Dis Child. 2010 Aug 12.
59. Empirical treatment of septic neonates- are the current guidelines adequate? B Muller-Pebody, AP
Johnson, PT Heath, RE Gilbert, KL Henderson, M Sharland. Arch Dis Child Fetal Neonatal Ed. 2011
Jan;96(1):F4-8.
60. Neonatal infections in England: the NeonIN network. Stefania Vergnano, Esse Menson, Nigel
Kennea, Nick D Embleton, Alison Ruth Bedford Russell, Timothy Watts, Mike J Robinson, Andrew
Collinson, and Paul T Heath. Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F9-F14.
61. Risk factors for late onset Gram-negative Infections: A Case Control Study
Srabani Samanta, Kate Farrer, Aodhan Breathnach, and Paul T Heath. Arch Dis Child Fetal Neonatal
Ed. 2011 Jan;96(1):F15-8.
62. Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, and
Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted split-virion vs. non-adjuvanted whole
virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. Claire Waddington, Woolf
Walker, Clarisa Oeser, Amanda Reiner, Tessa John, Suzanne Wilkins, Michelle Casey, Polly
Eccleston, Ruth Allen, Ifeanyichukwu Okike, Shamez Ladhani, Elizabeth Sheasby, Katja Hoschler,
Nick Andrews, Pauline Waight, Andrew Collinson, Paul T Heath, Adam Finn, Saul Faust, Matthew
David Snape, Elizabeth Miller, and Andrew J Pollard. BMJ. 2010 May 27;340:c2649.
63. Ladhani Shamez N; Davila Sonia; Hibberd Martin L; Heath Paul T; Ramsay Mary E; Slack Mary P
E; Pollard Andrew J; Booy Robert. Association between single-nucleotide polymorphisms in
Mal/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b
infection in immunized children. Clinical infectious Diseases 2010;51(7):761-7.
64. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the
manifestations, management, and outcome of the disease. Claire A Booth, Kimberly C Gilmour, Paul
Veys, Andrew R Gennery, Mary A Slatter, Helen Chapel, Paul Heath, Colin G Steward, Owen Smith,
Anna O'Meara, Hilary Kerrigan, Nizar Mahlaoui, Marina Cavazzana-Calvo, Alain Fischer, Despina
Moshous, Stephane Blanche, Jana Pachlopnik-Schmid, Sylvain Latour, Genevieve de Saint Basile,
Michael Albert, Gundula Notheis, Nikolaus Rieber, Brigitte Strahm, Henrike Ritterbusch, Arjan
Lankester, Nico G Hartwig, Isabelle Meyts, Alessandro Plebani, Annarosa Soresina, Andrea Finocchi,
Claudio Pignata, Emilia Cirillo, Sonia Bonanomi, Christina Peters, Krzysztof Kalwak, Srdjan Pasic,
Petr Sedlacek, Janez Jazbec, Hirokazu Kanegane, Kim E Nichols, I Celine Hanson, Neena Kapoor,
Elie Haddad, Morton J Cowan, Sharon Choo, Joanne Smart, Peter D Arkwright, and Hubert B
Gaspar. Blood. 2011 Jan 6;117(1):53-62.
65. Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey
M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust
S, Snape M, Miller E, Pollard A. Open-label, randomised, parallel-group, multicentre study to evaluate
the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B))
split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12
years of age. Health Technol Assess. 2010 Oct;14(46):1-130
66. Matthew D. Snape, Chaam L. Klinger, Elvis D. Daniels,Tessa M. John, Helen Layton, Llinos
Rollinson, Sarah Pestridge, Sandra Dymond, Eva Galiza, Susan Tansey, Daniel A. Scott, Sherryl A.
Baker, Thomas R. Jones, Ly-Mee Yu, William C. Gruber, Emilio A. Emini, Saul N. Faust, Adam Finn,
Paul T. Heath, Andrew J. Pollard. Immunogenicity and Reactogenicity of a 13-Valent pneumococcal
Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. A Double-blind Randomized Activecontrolled Trial. Pediatr Infect Dis J. 2010 Dec;29(12):e80-90.
67. Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, Taj M, Heath PT, Miller E. Immunogenicity of
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 5 / 14
Curriculum Vitae
Paul Heath
pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis. 2010
Dec 15;51(12):e95-104.
68. Depani SJ, Ladhani S, Heath PT, Lamagni TL, Johnson AP, Pebody RG, Ramsay ME, Sharland
M. The Contribution of Infections to Neonatal Deaths in England and Wales. Pediatr Infect Dis J. 2011
Feb 11. [Epub ahead of print]
69. Stefania Vergnano, Esse Menson, Zoe Smith, Nigel Kennea, Nick D Embleton, Paul Clarke,
Timothy Watts, Paul T Heath. Characteristics of invasive Staphylococcus aureus in English neonatal
units. Pediatr Infect Dis J. 2011 Oct;30(10):850-4.
70. Kadambari S, Heath PT, Sharland M, Lewis S, Nicholls, A, Turner MA. Variation in gentamicin and
vancomycin dosage and monitoring in UK neonatal units. Journal of Antimicrobial Chemotherapy
2011 Nov;66(11):2647-50
71. Ifeanyichukwu O. Okike, Chee Yung, Shamez Ladhani, Clarissa Oeser, Aisleen Bennett, Katja
Doerholt, Sharon Storey, Sheila Donaghy, Nigel Butter, Katja Hoschler, Liz Sheasby, Paul T. Heath,
Elizabeth Miller. The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. Vaccine.
2011 Sep 2;29(38):6636-40
72. Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, Patel S, Wheatley K, Ramsay M,
Kearns PR, Hambleton S. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
Arch Dis Child. 2011 Sep;96(9)
73. Irja Lutsar, Ursula MT Trafojer, Paul T Heath, Tuuli Metsvaht, Joseph Standing, Susanna Esposito,
Vincent Meiffredi de Cabre, Clarissa Oeser and Jean-Pierre Aboulker. Meropenem vs standard of
care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a
randomised controlled trial. Trials. 2011 Sep 30;12:215
74. Shamez Ladhani, Clarissa Oeser, Joanne Sheldon, Mary Ramsay, Robert Booy, Paul T. Heath.
Immunoglobulin Deficiency in children with Hib vaccine failure. Vaccine. 2011 Nov 15;29(49):9137-40
75. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and nonadjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Andrews NJ, Walker WT, Finn A,
Heath PT, Collinson AC, Pollard AJ, Snape MD, Faust SN, Waight PA, Hoschler K, Sheasby L,
Waddington C, Kerridge S, Chalk J, Reiner A, John T, Fletcher M, Allen R, Fineman N, Wilkins S,
Casey M, Michaelis L, Oeser C, Okike I, Ladhani S, Miller E. Vaccine. 2011 Oct 19;29(45):7913-9.
Epub 2011 Aug 27.
76. Immunization status of children with HIV: failure to protect a vulnerable population. Zinna S,
Bamford A, Cunnington A, Kampmann B, Lyall E, Menson E, Heath P. HIV Med. 2011 Aug;12(7):4478
77. KM Edmond, C Kortsalioudaki, S Scott, S Schrag, A Zaidi, S Cousens, PT Heath. Group B
streptococcal disease in infants under 3 months; systematic review and meta-analysis. Lancet.
2012;379(9815):547-56.
78. Woolf T. Walker, Philip de Whalley, Nick Andrews, Clarissa Oeser, Michelle Casey, Louise
Michaelis, Katja Hoschler, Caroline Harrill, Phoebe Moulsdale, Ben Thompson, Claire Jones, Jem
Chalk, Simon Kerridge, Tessa M. John, Ifeanyichukwu Okike, Shamez Ladhani, Richard Tomlinson,
Paul T. Heath, Elizabeth Miller, Saul N. Faust, Matthew D Snape, Adam Finn , Andrew J. Pollard.
H1N1 antibody persistence one year after immunisation with an adjuvanted or whole virion pandemic
vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicentre follow-on study. Clin Infect Dis. 2012 Mar 1;54(5):661-9
79. Alice E Martin, Stefania Vergnano, Mark Anthony, Alison Bedford Russell, Nigel Kennea, Timothy
Watts, Nick Embleton, Paul T Heath, Andrew Collinson. Early Onset Group B Streptococcus –
Guidelines Review. Journal of Infection Prevention May 2012 vol. 13 no. 3 75-78.
80. Claudia Turner, Paul Turner, Linda Po, Naw Maner, Aruni De Zoysa, Baharak Afshar, Androulla
Efstratiou, Paul T Heath and François Nosten. Group B Streptococcal carriage, serotype distribution
and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the
Thai - Myanmar border. BMC Infect Dis. 2012 Feb 8;12:34
81. Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Anaphylaxis as an adverse event following
immunisation in the UK and Ireland. Arch Dis Child. 2012 Jun;97(6):487-90
82. de Whalley P, Walker W, Snape MD, Oeser C, Casey M, Moulsdale P, Harrill C, Andrews N,
Hoschler K, Thompson B, Jones C, Chalk J, Kerridge S, Tomlinson R, Heath PT, Finn A, Faust S,
Miller E, Pollard AJ. A 1-year follow-on study from a randomised, head-to-head, multicentre, openlabel study of two pandemic influenza vaccines in children. Health Technol Assess. 2011
Dec;15(45):v-vi, xi-xiii, 1-128.
83. Neonatal sepsis - many blood samples, few positive cultures: implications for improving antibiotic
prescribing. Blackburn RM, Muller-Pebody B, Planche T, Johnson A, Hopkins S, Sharland M, Kennea
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 6 / 14
Curriculum Vitae
Paul Heath
N, Heath PT. Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F487-8
84. Oeser C, Lamagni T, Heath PT, Sharland M, Ladhani S. The epidemiology of neonatal and
pediatric candidemia in England and wales, 2000-2009. Pediatr Infect Dis J. 2013 Jan;32(1):23-6
85. Khatami A, Snape MD, Ohene-Kena B, Young K, Oeser C, Michaelis LJ, Macleod E, Smee H,
Van Der Meeren O, Leyssen M, Caubet M, Yu L-M, Heath PT, Faust SN, Finn A, Pollard AJ. Phase II
study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month
Hib-MenC-TT booster in healthy infants. Pediatr Infect Dis J. 2013;32(6):675-681.
86. The changing antibiotic susceptibility of bloodstream infections in the first month of life: informing
antibiotic policies for early- and late-onset neonatal sepsis. Blackburn RM, Verlander NQ, Heath PT,
Muller-Pebody B. Epidemiol Infect. 2013 Jul 11:1-9).
87. The United Kingdom Primary Immune Deficiency (UKPID) Registry: Report of the first 4 years'
activity 2008-2012. Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, Reiser V,
Panahloo Z, Workman S, Slatter M, Gennery AR, Davies EG, Allwood Z, Arkwright PD, Helbert M,
Longhurst HJ, Grigoriadou S, Devlin LA, Huissoon A, Krishna MT, Hackett S, Kumararatne DS,
Condliffe AM, Baxendale H, Henderson K, Bethune C, Symons C, Wood P, Ford K, Patel S, Jain R,
Jolles S, El-Shanawany T, Alachkar H, Herwadkar A, Sargur R, Shrimpton A, Hayman G, Abuzakouk
M, Spickett G, Darroch CJ, Paulus S, Marshall SE, McDermott EM, Heath PT, Herriot R, Noorani S,
Turner M, Khan S, Grimbacher B. Clin Exp Immunol. 2013 Jul 11.
88. Trends in paediatric nosocomial bacteraemia in a London tertiary hospital. Pérerz Lopéz A,
Ladhani SN, Breathnach A, Planche T, Heath PT, Sharland M. Acta Paediatr. 2013 Jul 9.
89. A three year descriptive study of early onset neonatal sepsis in a refugee population on the
Thailand Myanmar border. Turner C, Turner P, Hoogenboom G, Aye Mya Thein N, McGready R,
Phakaudom K, De Zoysa A, Efstratiou A, Heath PT, Nosten F. BMC Infect Dis. 2013 Dec 21;13:601.
90. Attitudes towards vaccination against group B streptococcus in pregnancy. McQuaid F, Jones C,
Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Snape MD. Arch Dis Child. 2013 Dec 19
91. Le Doare K, Bielicki J, Heath PT, Sharland M. Systematic review of antibiotic resistance rates
among Gram-negative bacteria in children with sepsis in resource-limited countries. Journal of the
Pediatric Infectious Diseases Society 2014 (in press).
92. Oeser, Clarissa; Vergnano, Stefania; Naidoo, Ronelle; Anthony, Mark; Chang, John; Chow, Peter;
Clarke, Paul; Embleton, Nick; Kennea, Nigel; Pattnayak, Santosh; Reichert, Bernd; Scorrer, Timothy;
Tiron, Irina; Watts, Timothy; Sharland, Michael; Heath, Paul. Neonatal Invasive Fungal Infection in
England 2004-2010. Clin Microbiol Infect. 2014 Jan 30.
93. Irja Lutsar, Corine Chazallon, Francesca Ippolita Calo Carducci, Ursula Trafojer, Ben Abdelkader,
Vincent Meiffredy de Cabre, SusannaEsposito, Carlo Giaquinto, Paul T Heath, Mari-Liis Ilmoja,
Aspasia Katragkou, Carine Lascoux, Tuuli Metsvaht, George Mitsiakos, Emmanuelle Netzer, Lorenza
Pugni, Emmanuel Roilides, Yacine Saidi, Kosmas Sarafidis, Mike Sharland, Vytautas Usonis and
Jean-Pierre Aboulker. Current management of late onset neonatal bacterial sepsis in five European
countries. European Journal of Pediatrics 2014 (in press)
94. Okike IO, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. Trends in bacterial,
mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet
Infect Dis. 2014 Apr;14(4):301-7.
95. Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant
Immunization: Follow-Up from a Randomized Controlled Trial. Trück J, Snape MD, Tatangeli F,
Voysey M, Yu LM, Faust SN, Heath PT, Finn A, Pollard AJ. PLoS One. 2014 Mar 11;9(3):e91413
96. Soonie R. Patel, Jessica Bate, Peter A.C. Maple, Kevin Brown, Judith Breuer, Paul T. Heath.
Varicella Zoster Immune Status in Children Treated for Acute Leukaemia. Pediatric Blood & Cancer
2014 (in press).
97. R.C. Read, D. Baxter, D.R. Chadwick, S.N. Faust, A. Finn, S. Gordon, P.T. Heath, D.J.M Lewis,
A.J. Pollard, D.P.J. Turner, R. Bazaz, T. Ganguli, T. Havelock, K.R. Neal, I. Okike, B. Morales-Aza, K.
Patel, M.D. Snape, J. Williams, S. Gilchrist, S.J. Gray, M.C.J. Maiden, D. Toneatto, H. Wang , M.
McCarthy, P.M. Dull, R. Borrow. Impact of a quadrivalent meningococcal ACWY glycoconjugate or a
serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3
randomised clinical trial. Lancet 2014 (in press).
98. Kadambari S, Okike I, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. Seven-fold
increase in viral meningo-encephalitis reports in England and Wales during 2004-2013. J Infect. 2014
Jun.
99. Ifeanyichukwu O. Okike, Alan P. Johnson, Katherine L. Henderson, Ruth M. Blackburn, Berit
Muller-Pebody, Shamez N Ladhani, Mark Anthony, Nelly Ninis, Paul T. Heath and the neoMen study
group. Incidence, Aetiology and Outcome of Bacterial Meningitis in Infants aged <90 days in the
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 7 / 14
Curriculum Vitae
Paul Heath
United Kingdom and Republic of Ireland: prospective, enhanced, national population-based
surveillance. Clinical Infectious Diseases 2014 (in press).
100. Payne H, Judd A, Donegan K, Okike IO, Ladhani S, Doerholt K, Heath PT. Incidence of
pneumococcal and varicella disease in HIV-infected children and adolescents in the UK and Ireland,
1996-2011. Pediatr Infect Dis J. 2014 (in press).
101. Kadambari S, Botgros A, Clarke P, Vergnano S, Anthony M, Chang J, Collinson A, Embleton N,
Kennea N, Settle P, Heath PT, Menson EN on behalf of the neonIN neonatal infection surveillance
network. Characterising the burden of invasive Pseudomonas infection on neonatal units in the UK
between 2005-2011. Journal of Hospital Infection 2014 (in press).
102. Manish Sadarangani, Louise Willis, Seilesh Kadambari, Stuart Gormley, Zoe Young, Rebecca
Beckley, Katherine Gantlett, Katharine Orf, Sarah Blakey, Natalie G Martin, Dominic F Kelly, Paul T
Heath, Simon Nadel, Andrew J Pollard. Childhood meningitis in the conjugate vaccine era:
prospective cohort study. Archives of Disease in Childhood 2014 (in press)
Commissioned articles / chapters:
1. Herbert MA, Heath PT, Mayon-White RT. Meningococcal vaccines for the United
Kingdom.Communicable Disease Report 1995;5:R130-135.
2. Heath PT, Moxon ER. Haemophilus influenzae type b vaccination. Journal of Family Medicine
1996;21:39-43.
3. Mayon-White RT, Heath PT. Annotation: "Preventative strategies on meningococcal disease".
Archives of Disease in Childhood 1997;76 (3):178-81
4. Heath PT. " Haemophilus influenzae type b conjugate vaccines: a review of efficacy data".
Paediatric Infectious Diseases Journal 1998;17:S36-42 .
5. Heath PT, Maclennan JM, Moxon ER. Polio vaccine: is it time for a change? Commentary. Archives
of Disease in Childhood 1998;78:573-4
6. Heath PT, Moxon ER. "Haemophilus influenzae". Forfar & Arneil`s Textbook of Paediatrics. Fifth
and Sixth Editions. Churchill Livingstone. (1998 and 2002).
7. Wenger J, Booy R, Heath PT, Moxon ER. "Epidemiologic impact of conjugate vaccines on invasive
disease caused by Haemophilus influenzae type b." Levine et al (Ed). New Generation Vaccines. 2nd
edition. Marcel Dekker, Inc. (1998).
8. Heath PT, Moxon ER. "Specific Vaccines." Root RK (Ed). Clinical Infectious Diseases: A Practical
Approach. Oxford University Press. (1999).
9. Nicoll A, Heath PT. Group B Streptococcal infection. Commentary. Arch Dis Child Fetal Neonatal Ed
2000, 82(3) F207
10. Sidwell R, Heath PT. “Infectious Diseases”. Sidwell R, Thomson M (Eds). Concise
Paediatrics.Greenwich Medical Media Ltd. (2000).
11. Heath PT. Epidemiology and bacteriology of bacterial pneumonias. Paediatric Respiratory
Reviews 2000;1:4-7
12. Heath PT, Denvir L. Pertussis. MEDICINE 2001;29:3:91-92.
13. Heath PT. Bacterial infection and the neonate. Chapter in: Infection and Pregnancy, RCOG, 2000.
14. Heath PT, Breathnach AS.. Treatment of infections due to resistant organisms. In: Childhood
Respiratory Infections. British Medical Bulletin 2002; 58(1): Chapter 15.
15. Mohan PV, Heath PT. Pneumococcal Disease in Childhood. Hospital Medicine 2001;62:406-9.
16. Coote NMA, Craig J, Heath PT, McKenzie SA, Saul P, Smyth R, Thomson AH. BTS Guidelines for
the management of community acquired pneumonia in childhood. Thorax 2002;57: i1e24.
17. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002;86:396-99.
18. Finn A, Booy R, Moxon R, Sharland M, Heath P. Should the new pneumococcal vaccine be used
in high-risk children? Arch Dis Child 2002;87:18-21.
19. Heath PT, Nik Yusoff NK, Baker CJ. Neonatal Meningitis. Arch Dis Child Fetal Neonatal Ed. 2003
88(3):F173-8.
20. Rueggeberg J, Heath PT. Safety and Efficacy of Meningococcal group C conjugate vaccines.
Expert Opinion on Drug Safety. 2003;2(1): 7-79.
21. McVernon J, Heath PT. Re-inforcement of Hib immunisation required. Communicable Disease
and Public Health. 2003;6(1):2.
22. Heath PT, Ramsay ME. Haemophilus influenzae type b vaccine--booster campaign. BMJ.
2003;326(7400):1158-9.
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 8 / 14
Curriculum Vitae
Paul Heath
23. Vergnano S, Heath PT. Neisseria meningitidis serogroup A vaccines: an overview. Expert Rev.
Vaccines 2003; 2(4):571-582.
24. Menson E, Heath PT. Strategies for preventing group B streptococcal disease. Adv Exp Med Biol,
549, 231-236 (2004).
25. Stefania Vergnano, Peter Kazembe, Charles Mwansambo, Mike Sharland, Paul T Heath.
Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005; 90(3):F220-4.
26. Law MR, Palomaki G, Alfirevic Z, Gilbert G, Heath P, McCartney C, Reid T, Schrag S. The
prevention of neonatal Group B streptococcal disease. J Med Screen. 2005;12(2):60-8.
27. Heath PT, Feldman RG. Vaccination against Group B streptococcus. Expert Rev Vaccines.
2005;4(2):207-18.
28. Finn A, Heath P. Conjugate vaccines. Archives of Disease in Childhood 2005: 90: 667-9.
29. Sinha R, Heath PT. Pertussis. MEDICINE 2005;33: 101-2
30. Bonhoeffer, J, Heath PT. Update on new vaccines and immunisation strategies. Current
Paediatrics. 2006;16:1-7.
31. Bonhoeffer, J, Siegrist, CA, Heath PT. Immunisation of premature infants. Archives of Disease in
Childhood. 2006; 91:929-35
32. Heath PT. "Haemophilus influenzae". 7th Edition of Forfar and Arneil's Textbook of Pediatrics.
Editors McIntosh, Helms, Smyth and Logan. 2007
33. Heath PT. “Infection and immunity in the newborn”. 7th Edition of Forfar and Arneil's Textbook of
Pediatrics. Editors McIntosh, Helms, Smyth and Logan. 2007
34. Heath P and Schuchat A. “Perinatal Group B Streptococcal disease”. Best Pract Res Clin Obstet
Gynaecol. 2007 Jun;21(3):411-24.
35. Erlewyn-Lajeunesse M, Bonhoeffer J, Ruggeberg JU, Heath PT. Anaphylaxis as an adverse event
following immunization. J Clin Pathol. 2007 Jul;60(7):737-9.
36. Pneumococcal conjugate vaccines. A review. Minerva Med. 2007 Apr;98(2):131-43.
37. Conterno LO, Heath PT. Seroprotection against serogroup C meningococcal disease. BMJ. 2008
Jun 5
38. Patel SR, Chisholm JC, Heath PT. Vaccinations in children treated with standard-dose cancer
therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am. 2008 Feb;55(1):169-86
39. Soonie R Patel, Paul T Heath, Immunization in children with cancer. Paediatrics and Child Health
2008
40. Shamez Ladhani, Fiona Neely, Paul Heath, Bernadette Nazareth, Richard Roberts, Mary P.E.
Slack, Jodie McVernon, Mary E. Ramsay Recommendations for the prevention of secondary
Haemophilus influenzae type b (Hib) disease. Journal of Infection 2009.
41. Galiza EP, Heath PT. Improving the outcome of neonatal meningitis. Curr Opin Infect Dis
2009;22(3):229-34.
42. Galiza EP, Heath PT. Pertussis. Medicine. Volume 37, Issue 12, December 2009, Pages 635-637
43. Heath PT, Jardine LA. Neonatal infections: group B streptococcus. Clin Evid (Online). 2010 Sep
27;2010. pii: 0323.
44. Paul T. Heath, Ifeanyichukwu O. Okike Neonatal bacterial meningitis: an update. Paediatrics and
Child Health, Volume 20, Issue 11, November 2010, Pages 526-530.
45. Bedford Russell A, Sharland M, Heath PT. Improving antibiotic prescribing in neonatal units: time
to act. Arch. Dis. Child. Fetal Neonatal Ed. 2012;97 F141-F146
46. Heath PT, Okike IO, Oeser C. Neonatal meningitis: can we do better? Adv Exp Med Biol.
2011;719:11-24
47. Paul T. Heath, Chaamala L. Klinger and Christini Kortsalioudaki. Chapter: Group B Streptococcal
Infections. In: “New Challenges in Prenatal and Neonatal Infections” 2011
48. Heath PT. An update on vaccination against group B streptococcus. Expert Rev Vaccines. 2011
May;10(5):685-94.
49. Borrow R, Heath PT, Siegrist CA. Use of pneumococcal polysaccharide vaccine in children: what
is the evidence? Curr Opin Infect Dis. 2012 Apr 18
50. Guidance on vaccination of HIV-infected children in Europe. Menson E, Mellado M, Bamford A,
Castelli G, Duiculescu D, Marczyńska M, Navarro M, Scherpbier H, Heath P; the Paediatric European
Network for Treatment of AIDS (PENTA) Vaccines Group, PENTA Steering Committee and Children's
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 9 / 14
Curriculum Vitae
Paul Heath
HIV Association (CHIVA). HIV Med. 2012 Jul;13(6):333-336.
51. Sharland M, Ladhani S, Ramsay M, Heath P, Saxena S, Koshy E, Bottle A, Murray J, Griffiths P.
Chapter 6. Life Stage: Perinatal. Annual Report of the Chief Medical Officer. November 2012.
52. Okike IO, Lamont RF, Heath PT. Do we really need to worry about listeria in newborn infants?
Pediatr Infect Dis J. 2013 Apr;32(4):405-6.
53. Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Anthony M,
Bedford-Russell A, Cooper T, Fry C, Heath PT, Kennea N, McCartney M, Patel B, Pollard T, Sharland
M, Wilson P. Arch Dis Child Fetal Neonatal Ed. 2013 Jun 21.
54. Cunnington M, Kortsalioudaki C, Heath P. Genitourinary pathogens and preterm birth. Curr Opin
Infect Dis. 2013 Jun;26(3):219-30
55. Clinical trials in neonatal sepsis. Oeser C, Lutsar I, Metsvaht T, Turner MA, Heath PT, Sharland M.
J Antimicrob Chemother. 2013 Jul 30
56. An overview of global GBS epidemiology. Le Doare K, Heath PT. Vaccine. 2013 Aug 28;31 Suppl
4:D7-D12.
57. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein
conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in
young-infants. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM.
Vaccine. 2013 Aug 28;31 Suppl 4:D52-7
58. Paul T. Heath and Luke Anthony Jardine. Neonatal infections: group B streptococcus. BMJ Clinical
Evidence 2014.
59. Alison Kent, Mark A Turner, Mike Sharland and Paul T Heath. Aminoglycoside toxicity in neonates:
something to worry about? Expert Rev. Anti Infect. Ther. 12(3), 319–331 (2014)
Letters.
1. Booy R, Heath PT, Willocks L, Mayon-White R, Slack M, Moxon ER. Invasive Pneumococcal
Infections in Childhood. Lancet 1995;345:1245-6.
2. Heath PT, Booy R, Slack MPE, Moxon ER. Are Hib booster vaccinations redundant? Lancet
1997;350:817.
3. Rushdy A, Ramsay M, Heath PT, Azzopardi H, Slack M. Infant Hib vaccination and herd immunity.
Journal of Paediatrics 1999;134(2):253-4
4. McCartney AC, Heath P, Hughes R, Mifsud A, Price E. The ORACLE I and II randomised trial
results do not remove the need for prophylaxis against early onset Group B streptococcal disease.
BJOG. 2002 Dec;109(12):1419-20.
5. Finn A, Booy R, Moxon R, Sharland M, Heath P. Conflicting advice. Arch Dis Child. 2003
Feb;88(2):176.
6. McVernon, Ramsay, Heath, Slack, Moxon. Haemophilus influenzae type b epiglottitis. Article gives
timely lesson. BMJ 2003;326:284
7. Ramsay ME, Miller E, Andrews N, Slack M, Heath P. Epidemiological data are essential (Rapid
response). BMJ, 16 December 2004.
8. Patel SR, Cohen B, Brown D, Heath PT. Reply to Arya and Agarwal and Meisel and Dilloo. Clin
Infect Dis. 2007 Aug 1;45(3):398-399
9. Stenson B, Heath PT, Bedford Russell A. Respiratory Distress Related to Asymptomatic
Colonisation with Group B Streptococci. PIDJ 2007; 26:765.
10. Expediting clinical trials in a pandemic. Pollard AJ, Reiner A, John T, Sheasby E, Snape M, Faust
S, Collinson A, Finn A, Heath PT, Miller E. BMJ. 2009 Nov 10;339:b4652.
11. Bate J, Chisholm J, Skinner R, Breuer J, Ramsay M, Wheatley K, Hambleton S, Heath PT.
Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled
trial. Arch Dis Child. 2012 Sep;97(9):853-4
12. Heath PT. Rapid Response. Re: Introducing a new group B meningococcus vaccine. 23 April,
2014. (http://www.bmj.com/content/348/bmj.g2415/rr/695395)
Editorial duties.
Section Editor. Paediatric and Neonatal Infections. Current Opinions In Infectious Diseases. 2006 2015
Editorial Board. “Vaccines In Practice”. Hayward Medical Communications. 2009-2012
Section Editor. RCPCH manual of infections (Blue Book) 2010, 2014
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 10 / 14
Curriculum Vitae
Paul Heath
Associate Editor. BMC Infectious Diseases. 2011
Guest Editor. International Journal of Paediatrics. Neonatal sepsis issue. 2011.
Projects
Memberships
PREVIOUS APPOINTMENTS
• Member of Advisory Group for the Special Risk Research Program (Immunisation CCRE - Murdoch
Childrens Research Institute), Melbourne, Australia.
• Member of European Society of Paediatric Infectious Diseases Committee for Scientific Affairs &
Awards
• Member of HPA Healthcare associated infections steering group
• Member of Independent Data Monitoring Committee. GlaxoSmithKline Pandemic Influenza
vaccines.
• National Patient Safety Agency: Safer Practice in Neonatal Care Project. Chairman of Infection
Expert Group.
• Member. National Institute of Clinical Excellence. Meningitis and meningococcal disease. Guideline
Development Group.
• Member of Department of Health Joint Committee on Vaccination and Immunisation (JCVI)
– Varicella subgroup
• Member Action Medical Research Scientific Advisory Panel
• Member. National Institute of Clinical Excellence. Neonatal infections. Guideline Development
Group.
• British Thoracic Society committee on pandemic swine flu management guidelines
CURRENT APPOINTMENTS
• Member of Health Protection Agency (HPA) Vaccine Preventable Invasive Bacterial Infections Forum
• Member of RCPCH Vaccination of the Immunocompromised Child Guidelines Committee
• Member of Department of Health Joint Committee on Vaccination and Immunisation (JCVI)
– Pneumococcal subgroup
• Member of Royal College of Obstetricians & Gynaecologists: Group B streptococcal prevention
guidelines committee
• South London Children's Specialty Group Clinical Lead
• Member. European PENTA vaccination guidelines group
• Member of European Society of Paediatric Infectious Diseases Committee for Research
• Secretary. United Kingdom Paediatric Vaccine Group (UKPVG)
• Scientific Member of the MCRN/BPAIIG Allergy / Infectious disease and Immunity Clinical Studies
Group (CSG).
• Moderator: Brighton International Collaboration on Vaccine safety “Clinical advisory forum of
experts”.
• Co-Lead Clinical Advisor: RCOG/LSHTM audit: Improving the prevention of early-onset Group B
Streptococcal (EOGBS) disease in the UK
• NICE Quality Standard Advisory Committee: specialist committee member for Antibiotics for
neonatal infection
• NICE Antibiotics for early onset neonatal infection: member of Evidence Update Advisory Group
• Member: Meningitis Research Foundation’s Medical Advisory Group
Other Relevant Information
Higher degrees examined.
MPhil to DPhil. University of London (SGHMS), 2001.
PhD. University of Edinburgh, 2002.
PhD. University of London (LSHTM), 2004.
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 11 / 14
Curriculum Vitae
Paul Heath
PhD. Oxford Brooks University, 2006.
MD. University of London (QMUL), 2007.
MD. University of Newcastle, 2007.
MPhil to DPhil. University of London (SGUL). 2009.
MPhil to DPhil. University of London (SGUL). 2010
MPhil to DPhil. University of London (SGUL). 2010
PhD. University of Perth, Australia. 2011.
MPhil to DPhil. University of London (LSHTM), 2012
PhD. Imperial College, 2013
PhD. University of Witwatersrand, South Africa, 2013
MD. Newcastle University, 2013.
PhD Northumbria University, 2013
PhD University of Malawi, 2014
National and International Invited lectures.
2005. “Group B streptococcal Disease”. European Society of Paediatric Infectious Diseases “Meet the
Professor session”, Valencia, Spain.
2005. Haemophilus influenzae type b”. Spanish Paediatric Association, Las Palmas, Spain.
2005. “Pertussis” and “Hib vaccines”. Malaysian Paediatric Association Annual meeting, Kota
Kinabalu, Malaysia.
2005. “Conjugate vaccines”. Meningitis Research Foundation. National Meningitis Meeting. London.
2006. “Hib vaccines”. Taiwanese Paediatric Association. Taipei.
2006. “GBS vaccines”. Spanish Association of Vaccinology, Seville, Spain.
2006. “GBS disease”. ESPID, Basel.
2006. “Adverse events after immunisation”. National Immunisation Conference for Health Care
Workers, Manchester
2006. “GBS vaccines” and “New quadravalent meningococcal vaccines” Meningitis Research
Foundation. London.
2007. “European practices on vaccination of the premature infants”, Advances in Paediatric Infectious
Diseases. Milan.
2007. “GBS infections, prophylaxis and vaccines”, World Society of Paediatric Infectious Diseases,
Bangkok.
2008 “Vaccination of premature infants.” Berzelius Symposium: Vaccine Development in the 21st
Century, Swedish Society of Medicine, Stockholm, Sweden.
2008 “Meningococcal C vaccination in the UK”. German Society of Pediatric Infectious Diseases.
Erlangen, Germany.
2008. Infection and immunity in children. Oxford. “Prophylaxis and prevention of Group B
streptococcal disease”.
2008. “Pneumococcal and Hib infections”. Vaccinology Course. Pasteur Institute, Paris.
2008. “Vaccination of HIV-Infected children”. Annual Conference of the Children’s HIV Association
(CHIVA), Liverpool.
2008. “Vaccination of risk groups”. HPA Scientific Issues in Immunisation conference, London.
2008. Swedish Centre for Disease Control. “Premature infant vaccination”, Stockholm.
2009. “Future vaccines”. HPA/ICH Fundamentals of Immunisation Course, London.
2009. “Neonatal meningitis” MRF international conference, London.
2009. “GBS vaccines” International Neonatal and Maternal Immunization Symposium, Turkey.
2009 “Pneumococcal and Hib infections”. Vaccinology Course. Pasteur Institute, Paris.
2009. “Neonatal infections”. Infection and Vaccines, Coimbra, Portugal.
2009. “Vaccination of premature infants”. European Society for Developmental Perinatal & Paediatric
Pharmacology, Chamonix.
2009. “European neonatal infections”. PID Meeting, Milan
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 12 / 14
Curriculum Vitae
Paul Heath
2009. “GBS vaccines”. SGM Autumn Meeting - Heriot-Watt University, Edinburgh.
2010 “Pneumococcal and Hib infections”. Vaccinology Course. Pasteur Institute, Paris.
2010. GBS Symposium, London. “Group B streptococcal vaccines”.
2010. Infection and immunity in children. Oxford. “Neonatal meningitis”.
2010. Expert Meeting on Paediatric Severe Sepsis. EMA, Rome
2010. Nordic Vaccine meeting. “Vaccinating premature infants”, Stockholm.
2010. “GBS vaccines”. Excellence in Paediatrics, London.
2010. “Neonatal infections”. Neonatology. Royal Society of Medicine, London
2010. “Future vaccines”. HPA/ICH Fundamentals of Immunisation Course, London.
2010. 14th ICID "Bacterial Meningitis: Prevention and Cure": “neonatal and paediatric bacterial
meningitis”, Miami.
2010. “Fever and immunisation”. 21st national Immunisation conference for Health Care Workers,
Manchester.
2010. “GBS disease”. RCOG Annual Professional Development Conference – GBS, London.
2011.
“Pneumococcal and Hib infections”. Vaccinology Course. Pasteur Institute, Paris.
“Group B streptococcal vaccines”. ESCMID Conference, Prague.
“Group B streptococcal vaccines”. Society for General Microbiology, Harrogate.
Welsh Immunisation Conference. “Fever and Immunisation”. Cardiff.
“Neonatal infections”. Athens.
European Society of Paediatric Infectious Diseases. “Neonatal infections”.
The Hague.
European Society of Paediatric Research. “Neonatal infections”. Newcastle.
“Future vaccines”. HPA/ICH Fundamentals of Immunisation Course, London.
“Combination vaccines”. 22nd national Immunisation conference for Health Care Workers,
Manchester.
2012.
“Vaccinating preterm infants”. Vaccinology Masterclass. The Netherlands
“Pneumococcal and Hib infections”. Vaccinology Course. Pasteur Institute, Paris.
“Late onset neonatal infections” . ESPID, Greece.
“Vaccination of oncology patients”. SIOP conference, London
“Epidemiology of GBS infections”, Siena, Italy.
“Maternal vaccination with meningococcal vaccines”. Annercy, France.
“Early onset neonatal Infections”. Neonatal Update:The Science of Newborn Care, London.
2013.
“Vaccinating preterm infants”. Vaccinology Masterclass. The Netherlands
“Pneumococcal and Hib infections”. Vaccinology Course. Pasteur Institute, Paris.
“GBS infections” and “Maternal vaccination with meningococcal vaccines”, INMIS, Turkey
“Neonatal Infections”. ESPID, Milan.
“Maternal vaccination”. ECCMID, Prague.
“Neonatal meningitis”. Meningitis Trust symposium, Bristol.
“Maternal vaccination”. National Healthworkers immunisation conference, Manchester.
Chair “GBS meningitis session”, MRF conference, London.
“Global burden of neonatal infections”. WSPID, Capetown.
2014.
“GBS vaccine development” & “Why vaccinate against Meningococcal B” Oxford Vaccine Group 11th
Immunisation Seminar, Oxford
“Meningococcal B vaccine”. Royal College of Paediatrics and Child Health Annual meeting,
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 13 / 14
Curriculum Vitae
Paul Heath
Birmingham
“Neonatal infections”. London Deanery. Royal Society of Medicine.
“Vaccinating preterm infants”. National Healthworkers immunisation conference, Manchester
Referee for Journals:
Archives of Disease in Childhood, British Medical Journal, Journal of Infectious Diseases, Pediatric
Infectious Disease Journal, Pediatrics, Vaccine, Lancet, Cochrane reviews, Journal of Paediatrics,
Journal of Medical Microbiology, Journal of Antimicrobial Chemotherapy
Referee for Grants & Research:
Wellcome Trust, Meningitis Research Foundation, Action Medical Research,
Independent expert to the European Commission FP7 Health research call,
The Netherlands Organisation for Health Research and Development, Portuguese
Foundation for Science and Technology, Thrasher Research Fund (USA), Health Research Council of
New Zealand.
29/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 14 / 14